BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Selcodebart readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Selcodebart\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05320198-928@assetmemo.bio
DTSTAMP:20261121T003714Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:Selcodebart: Phase 1/2 readout est. (NCT05320198)
DESCRIPTION:Selcodebart\, phase 1/2\, Anemia of Myelofibrosis.\nStudy: Stud
 y of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodyspl
 astic Syndrome and Anemia\nEstimated primary completion: May 2027. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/selcodebart#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT05320198
URL:https://assetmemo.bio/drug/selcodebart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
